Best Practices for Research Compliance

Dr. Andrzejewski holds a doctoral degree in Teacher Education Policy and Leadership, with cognates in Qualitative Research Methods and Movement Studies. She is an experienced member of Auburn’s IRB and is a CCTS-certified research mentor. She is award-winning teacher and serves as the education and training consultant for the Office of Research Integrity and Compliance. In that role, she leads research mentoring workshops and offers Responsible Conduct of Research (RCR) coursework.

Dr. Wilson holds a doctoral degree in Applied Biology. He has served as a USDA Panel Manager and an NSF Program Director. He conducts faculty mentoring workshops at Auburn University and has served as a research mentor for over 100 graduate and undergrad students. His work is published in outlets such as Biology Letters, Ecology Letters, and BioScience. NSF, USDA, and USGS have funded projects for which he is PI/Co-PI.

Dr. Cremaschi holds a doctoral degree in Mechanical Engineering with a focus on building energy efficiency and sustainability. He has developed mentoring workshops and actively works to expand research opportunities for broader ranges of students in STEM and the Human and Social Sciences. He has served as PI/Co-PI on several federally funded projects, including SBIR awards. A published researcher, Dr. Cremaschi has contributed to numerous academic journals and has served on review panels for major funding agencies such as the NSF, DOE, and DOD. He is an associate editor for the International Communications in Heat and Mass Transfer Journal, served as associate editor for the Science and Technology for the Built Environment Journal, and is the editor-in-chief for the Auburn University Journal of Undergraduate Scholarship. He also serves as the current President of the American Society of Thermal and Fluids Engineers.

Dr. Maxuitenko holds a doctoral degree in Pharmacology and Toxicology and brings over 20 years of experience leading animal research laboratories. As a study director for in vivo pharmacology studies, she has played a critical role in advancing drug candidates, four of which have received FDA approval, and has conducted extensive evaluations in cancer therapy. Currently, she serves as Co-PI on multiple federally funded projects, including two R01 grants and a foundation-supported award. Dr. Maxuitenko also has significant experience in grant development, having led the preparation of numerous research proposals, including Small Business Innovation Research (SBIR) submissions.